CBT · Analysis updated Nov 10, 2026, 6:00 PM ET
Why is Cabot Corporation (CBT) stock moving?
Cabot beat fiscal Q4 2026 estimates, with adjusted EPS of $1.61 against $1.55 expected and sales of $1.009B against $927M, and fiscal 2026 adjusted EPS of $6.42. The fiscal 2027 adjusted EPS guide of $6.15-$6.75 sits below the $7.01 consensus, and its midpoint of $6.45 is roughly flat on fiscal 2026. Analyst reactions are split: Truist kept a Buy with a $95 target, UBS kept a Neutral with its target cut to $80 from $86, and JPMorgan kept a sell rating and cut its target to $68 on Nov 10. Supportive items include a $50M DOE grant for battery conductive additive capacity and $43M of battery materials EBITDA, a product-line high. Price action fits this picture: the stock closed at $75.72 on earnings day Nov 2 on 617K shares, fell to $72.00 on Nov 3 on 771K shares, rebounded to $75.10 on Nov 4, and then slid to a $71.05 close on Nov 6. It closed at $72.19 on Nov 10, above JPMorgan's $68 target but well below UBS's $80 and Truist's $95. Volume has eased to about 285K-335K shares a day since Nov 6, close to pre-earnings levels.
News behind the analysis
- JP Morgan Maintains Underweight on Cabot, Lowers Price Target to $68JP Morgan kept its Underweight rating on Cabot and cut its price target to $68. The target sits below the latest close of $72.19.
- Analyst Rating Update for Cabot CorporationAnalyst Jeffrey Zekauskas maintained a sell rating on Cabot and lowered the price target to $68.
- UBS Maintains Neutral on Cabot, Lowers Price Target to $80UBS kept a Neutral rating and cut its price target to $80 from $86.
- UBS Adjusts Price Target on Cabot Corporation to $80 From $86UBS lowered its Cabot price target to $80 from $86 while keeping a neutral rating.
- Truist Securities Maintains Buy on Cabot, Lowers Price Target to $95Truist kept its Buy rating on Cabot and lowered its price target to $95.
- Cabot Q4 2026 Earnings Call TranscriptCabot reported fourth-quarter results on Nov 2 and the earnings call transcript was published. It covers the company's Q4 and fiscal 2026 performance.
- Cabot Corporation Reports Fourth Quarter and Fiscal Year 2026 ResultsQ4 diluted EPS was $1.25 and adjusted EPS $1.61. Fiscal 2026 diluted EPS was $4.02 and adjusted EPS $6.42.
- Cabot Corporation Issues Fiscal 2027 Earnings GuidanceCabot guided fiscal 2027 adjusted EPS to $6.15 to $6.75. That range is below the FactSet estimate of about $7.01.
- Cabot Q4 Adj. EPS $1.61 Beats $1.55 Estimate, Sales $1.009B Beat $927.344M EstimateCabot's fourth-quarter adjusted EPS and sales both beat analyst estimates. Sales were $1.009B against $927.3M expected.
- Cabot Sees FY2027 Adj EPS $6.15-$6.75 vs $7.01 EstCabot's fiscal 2027 adjusted EPS outlook of $6.15-$6.75 falls short of the $7.01 estimate.
About Cabot Corporation
Cabot Corporation is a Boston-based specialty chemicals company and one of the world's largest makers of carbon black, the fine black powder that strengthens tires and rubber goods. It also makes specialty carbons, fumed silica and other metal oxides, and a fast-growing range of conductive additives for lithium-ion batteries; Erica McLaughlin became CEO in late fiscal 2026.
How it makes money
Most profit comes from Reinforcement Materials, which sells carbon black to tire and industrial rubber makers, mostly under yearly customer contracts. The second segment, Performance Chemicals, sells specialty carbons, fumed metal oxides and battery conductive additives used in plastics, coatings, inks, electronics and EV batteries. Battery materials were expected to bring in about $40 million of EBITDA in fiscal 2026. Total revenue is roughly $3.7 billion a year (approximate), and fiscal 2026 adjusted EPS was about $6.42.
What usually moves CBT
- Tire production and yearly carbon black contract pricing
- Oil-based feedstock costs
- Electric-vehicle battery demand
- Industrial and auto activity in China, the Americas and Europe
- Share buybacks and dividends